Commission Implementing Decision (EU) 2026/1126 of 26 May 2026 concerning the extension of the action taken by the Malta Competition and Consumer Affairs Authority permitting the making available on the market and use of the biocidal product Wofasteril® SC super in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2026) 3265)

• CELEX: Implementing Decision (EU) 2026/1126
• Articles: 2

Article 1

The Malta Competition and Consumer Affairs Authority may extend until 23 June 2027 the action to permit the making available on the market and use of the biocidal product Wofasteril ® SC super for the decontamination of personal protective equipment of healthcare professionals in the High Degree Isolation Unit at Mater Dei Hospital in Msida, provided that it ensures that the product is only used under its supervision.

Article 2

This Decision is addressed to the Malta Competition and Consumer Affairs Authority.

It shall apply from 20 December 2025.